Context Capital Management, LLC - Q4 2019 holdings

$200 Million is the total value of Context Capital Management, LLC's 101 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 83.3% .

 Value Shares↓ Weighting
SellTEAM INCnote 5.000% 8/0$5,222,000
-37.0%
5,000,000
-33.3%
2.62%
-44.3%
SellINTERCEPT PHARMACEUTICALS INnote 2.000% 5/1$4,611,000
+2.9%
3,485,000
-30.1%
2.31%
-9.0%
SellLIGAND PHARMACEUTICALS INCnote 0.750% 5/1$2,028,000
-54.5%
2,350,000
-56.1%
1.02%
-59.8%
NFINU SellNETFIN ACQUISITION CORPunit 08/01/2024$764,000
-56.7%
75,000
-57.1%
0.38%
-61.7%
KXIN SellKAIXIN AUTO HLDGS$98,000
-10.1%
52,276
-13.3%
0.05%
-21.0%
BROGW ExitTWELVE SEAS INVESTMENT COMPA*w exp 12/22/202$0-1,400
-100.0%
0.00%
BROGR ExitTWELVE SEAS INVESTMENT COMPAright 12/22/2019$0-1,400
-100.0%
-0.00%
XYNPW ExitXYNOMIC PHARMACUTCLS HLDNG I*w exp 05/15/202$0-63,000
-100.0%
-0.00%
KERNW ExitAKERNA CORP*w exp 06/17/202$0-35,864
-100.0%
-0.02%
STNLW ExitSENTINEL ENERGY SVCS INC*w exp 11/02/202$0-170,401
-100.0%
-0.04%
PVT ExitPIVOTAL ACQUISITION CORP$0-12,029
-100.0%
-0.07%
ExitPRETIUM RES INCnote 2.250% 3/1$0-185,000
-100.0%
-0.11%
PVTWS ExitPIVOTAL ACQUISITION CORP*w exp 12/01/202$0-160,599
-100.0%
-0.12%
ExitPDL BIOPHARMA INCnote 2.750%12/0$0-700,000
-100.0%
-0.38%
ExitTILRAY INCdebt 5.000%10/0$0-1,150,000
-100.0%
-0.42%
HCCHU ExitHL ACQUISITIONS CORPunit 06/21/2023$0-75,073
-100.0%
-0.45%
TMCX ExitTRINITY MERGER CORP$0-99,068
-100.0%
-0.59%
ExitMFA FINL INCnote 6.250% 6/1$0-1,043,000
-100.0%
-0.61%
ExitCSG SYS INTL INCnote 4.250% 3/1$0-1,011,000
-100.0%
-0.65%
ExitPARATEK PHARMACEUTICALS INCnote 4.750% 5/0$0-1,600,000
-100.0%
-0.66%
ALGRU ExitALLEGRO MERGER CORPunit 12/31/2023$0-126,509
-100.0%
-0.76%
ExitSPLUNK INCnote 0.500% 9/1$0-2,000,000
-100.0%
-1.22%
BROGU ExitTWELVE SEAS INVESTMENT COMPAunit 06/21/2023$0-206,600
-100.0%
-1.27%
ExitIQIYI INCdebt 3.750%12/0$0-7,700,000
-100.0%
-4.35%
ExitPDL BIOPHARMA INCnote 2.750%12/0$0-10,344,000
-100.0%
-5.62%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-07
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
THERAVANCE BIOPHARMA INC23Q2 20224.7%
ENCORE CAPITAL GROUP INC19Q2 20196.2%
INTERCEPT PHARMACEUTICALS IN18Q4 20226.2%
INFINERA CORPORATION18Q1 20233.6%
TESLA MTRS INC16Q1 20194.9%
DISH NETWORK CORPORATION16Q3 20233.3%
ENDOLOGIX INC15Q2 201911.6%
OMEROS CORP15Q3 20233.1%
VANGUARD TOTAL STOCK MKT ETF15Q1 20203.9%
AMAG PHARMACEUTICALS INC14Q3 20207.7%

View Context Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Context Capital Management, LLC Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ELECTRO ENERGY INCFebruary 17, 2009326,1244.9%
IRONCLAD PERFORMANCE WEAR CORPSold outFebruary 17, 200900.0%
Jazz Technologies, Inc.Sold outFebruary 17, 200900.0%
VELOCITY EXPRESS CORPFebruary 17, 2009190,1045.3%
ATS CORPJune 17, 2008723,0733.6%
Ascend Acquisition Corp.Sold outJune 16, 200800.0%
HIGHBURY FINANCIAL INCSold outJune 16, 200800.0%
PRIMUS TELECOMMUNICATIONS GROUP INCSold outJune 16, 200800.0%
Good Harbor Partners Acquisition CorpSold outFebruary 13, 200800.0%
InfuSystem Holdings, IncFebruary 13, 2008152,3500.8%

View Context Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-02
SCHEDULE 13G2024-03-20
13F-HR/A2024-02-16
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR2023-05-08
13F-HR2023-02-14
13F-HR2022-11-07
13F-HR2022-08-03

View Context Capital Management, LLC's complete filings history.

Compare quarters

Export Context Capital Management, LLC's holdings